Concordance of PD-L1 Expression Between Core Biopsy and Resection Specimens of Non–Small Cell Lung Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pathology and Forensic Medicine,Surgery,Anatomy
Reference14 articles.
1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015
2. Immune checkpoint modulation for non-small cell lung cancer;Soria;Clin Cancer Res,2015
3. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat Rev Cancer,2014
4. Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients;Ilie;Virchows Arch,2016
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Programmed death-ligand 1 expression in carcinoma of unknown primary;BMC Cancer;2024-06-06
2. Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation;Archives of Pathology & Laboratory Medicine;2024-04-16
3. Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma;npj Precision Oncology;2024-03-27
4. PD-L1 assessment in lung cancer biopsies—pitfalls and limitations;The International Journal of Biological Markers;2023-12-18
5. Relationship between PD-L1 expression and molecular aberrances in lung adenocarcinoma with solid components;Journal of Thoracic Disease;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3